Skip to main content

Table 2 Relapse rates of clear cell carcinoma patients who received FSS

From: Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment?

stage author year number of patients relapse
Stage IA Kajiyama [23] 2008 4 0% (0/4)
Satoh [24] 2010 15 0% (0/15)
  total   19 0% (0/19)
Stage IC Schilder [22] 2001 5 0% (0/5)
Kajiyama [23] 2008 6 17% (1/6)
Satoh [24] 2010 15 33% (5/15)
  total   26 23% (6/26)